SurgoCap Partners’s NVIDIA NVDA Stock Holding History

SurgoCap Partners’s Portfolio NVDA Stock Details NVDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-500,000	Closed	-$67.1M	–	15
2024 Q4	$67.1M	Buy	+500,000	New	+$68.9M	3.46%	12

Other funds holding NVDA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

SurgoCap Partners's NVDA Position: Q2 2026 in Review

SurgoCap Partners sold out of NVIDIA (NVDA) in Q2 2026, closing a stake of 1,008,073 shares — an estimated $176M sold.

SurgoCap Partners first reported a position in NVDA in Q4 2023 and held it in 6 quarters. The position peaked at $176M in Q1 2026. 5,979 funds tracked by Wall St. Rank hold NVDA as of Q2 2026.

SurgoCap Partners reported no remaining NVIDIA position as of Q2 2026 after selling out during the quarter.
SurgoCap Partners sold 1,008,073 NVIDIA shares in Q2 2026, an estimated $176M.
SurgoCap Partners first reported a position in NVIDIA in Q4 2023 and held it in 6 quarters.
SurgoCap Partners's NVIDIA position peaked at $176M in Q1 2026.
5,979 funds tracked by Wall St. Rank held NVIDIA as of Q2 2026.

Based on SurgoCap Partners's 13F filing for Q2 2026, filed 14 Aug 2026.